You are herePharma News

Pharma News


Stem Cell Transplantation is good for Juvenile Myelomonocytic Leukemia Patients

A group of medical researchers suggest using stem cell transplantation to treat patients with a serious but a very rare form of chronic blood cancer 'Juvenile Myelomonocytic Leukemia' (JMML) has shown improved results. The study has been published in the journal Blood.


Researchers explain How damaged DNA is repaired

Karim Mekhail, a professor at the University of Toronto has revealed how a damaged DNA is transported within a cell and repaired. By using yeast cells, researchers discovered the DNA ambulance, which is a motor protein complex.


Mobile Phones Harmful Radiation may cause cancer

Study find a metabolic imbalance caused by radiation from your wireless devices could be the link to a number of health risks, such as various neurodegenerative diseases and cancer. This imbalance, also known as oxidative stress, is defined as "an imbalance between the production of reactive oxygen species (ROS) and antioxidant defense". The study  published in the journal Electromagnetic Biology & Medicine.


Fish Toxin may Potential Medication for cancer cure

Medical researchers at the University of Freiburg have claimed that fish toxin could be used as a potential medication for cancer. The Yersinia species of pathogens can cause the bubonic plague and serious gastrointestinal infections in humans. The study has been published in the journal Nature Communications.


Simple sniff test could detect autism

The way children sniff different aromas could form the basis of a test to accurately detect autism, a new study has found. Researchers have found that autistic children go right on sniffing in the same way, no matter how pleasant or awful the scent is. The findings suggest that non-verbal tests related to smell might serve as useful early indicators of autism spectrum disorder (ASD), the researchers said.


Diabetes drug may help fight obesity

A drug to treat diabetes can help obese people who don't have the disease lose weight and keep it off, a new study has found. Researchers found that 63 per cent of study participants given the drug liraglutide for 56 weeks lost at least 5 per cent of their body weight whereas just 27 per cent of the placebo group lost that much.


Prescription Glaucoma drugs may treat tuberculosis

Researchers discovered that ethoxzolamide, a sulfa-based compound found in many prescription glaucoma drugs, actually turns off the bacterium's ability to invade the immune system.  In a breakthrough discovery, Robert Abramovitch, a Michigan State University microbiologist, along with a graduate student have suggested that a common medication used to treat glaucoma could also be used to treat tuberculosis (TB). The study has been published in Antimicrobial Agents and Chemotherapy.


Placebo may Treat Drug Addiction, Pain Management

A study conducted at the University of Colorado Boulder suggest even a placebo with no medical value can ease pain in research participants. The study found in The Journal of Pain.


Apollo Children’s Hospital use da Vinca robot to successfully treat children

Apollo Children’s Hospital has recently performed surgeries on children using the da Vinci robot. Robotic procedures have proven to be highly precise and targeted. This technique provides advantages like quicker discharge time, minimal scarring, smaller incisions and less blood loss that conventional laparoscopy offers over open surgeries.


'Actos' consumption not associated to raise bladder cancer risk

Prior studies suggesting that diabetes drug 'Actos' might raise users' risk of bladder cancer but  new study found no evidence for such an effect. Instead, researchers found a link between the use of Actos (pioglitazone) and a rise in pancreatic cancer risk, but experts say it's too early to draw any conclusive link. The study is published in Journal of the American Medical Association.